Actionable news
All posts from Actionable news
Actionable news in NKTR: Nektar Therapeutics,

Nektar Therapeutics's President & CEO just cashed-in 125,000 options

Howard W Robin, Nektar Therapeutics's President & CEO and a director of the company, recently cashed-in 125,000 options. The options were exercised at prices ranging between $6.46 and $6.98, while the disposals took place at $13.52 per share, on November 11, 2015. Robin continues to hold 10,410 shares of the company. Robin operates out of San Francisco, CA. Some additional info was provided as follows:

This transaction was made pursuant to a Rule 10b5-1...